AC Immune SA
NASDAQ:ACIU
2.68 (USD) • At close January 15, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||||||
| Net Income
| -54.233 | -70.753 | -72.996 | -61.921 | 45.442 | -50.951 | -26.411 | -7.096 | 20.27 | 10.744 | -11.243 |
| Depreciation & Amortization
| 2.215 | 2.359 | 2.406 | 1.967 | 1.694 | 0.961 | 0.58 | 0.278 | 0.287 | 0.298 | 0.293 |
| Deferred Income Tax
| 0 | 0 | 0.13 | 0.371 | 0.509 | 0.131 | 0.177 | -0.083 | 0.049 | 0.017 | 0 |
| Stock Based Compensation
| 4.365 | 3.33 | 4.126 | 4.088 | 2.834 | 2.518 | 1.579 | 1.317 | 0.54 | 0.21 | 0.256 |
| Change In Working Capital
| -15.16 | -8.432 | 6.841 | -4.573 | 5.65 | 1.812 | -1.99 | 3.298 | 24.584 | -28.866 | -0.109 |
| Accounts Receivables
| -14.8 | 0.036 | -0.099 | -0.025 | -0.068 | 0.698 | -0.401 | -0.248 | 25.666 | -25.744 | 0.055 |
| Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables
| 0 | 0 | 0 | 0 | 0 | 0 | -2.853 | 2.592 | -0.141 | 0.341 | 0 |
| Other Working Capital
| -0.36 | -8.468 | 6.94 | -4.548 | 5.718 | 1.812 | 0.863 | 0.706 | 24.725 | -29.207 | -0.164 |
| Other Non Cash Items
| 2.405 | -0.072 | -6.196 | 0.551 | -0.909 | 1.451 | 3.971 | -3.36 | -1.646 | -0.027 | -9.001 |
| Operating Cash Flow
| -60.408 | -73.568 | -65.689 | -59.517 | 55.22 | -44.078 | -22.094 | -5.646 | 44.084 | -17.624 | -19.804 |
| Investing Activities: | |||||||||||
| Investments In Property Plant And Equipment
| -0.801 | -1.239 | -2.635 | -1.706 | -1.885 | -1.858 | -1.802 | -0.899 | -0.244 | -0.128 | -0.249 |
| Acquisitions Net
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| 0 | 0 | 0 | 0 | -65 | -30 | 0 | 0 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| 66.446 | 25.002 | -51.029 | 30.035 | -65 | -0.178 | -0.04 | 0 | 0 | -0.003 | 0 |
| Investing Cash Flow
| 65.645 | 23.763 | -53.664 | 28.329 | -66.885 | -32.036 | -1.842 | -0.899 | -0.244 | -0.131 | -0.249 |
| Financing Activities: | |||||||||||
| Debt Repayment
| -0.548 | -0.569 | 22.95 | -0.432 | 50.057 | 0.198 | 0.2 | 0 | 0.055 | 0 | 0 |
| Common Stock Issued
| 43.798 | 0 | 17.802 | 0.1 | 0 | 111.529 | 0 | 69.689 | 0 | 0 | 0 |
| Common Stock Repurchased
| 0 | 0 | 0 | -0.1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 0 | -0.776 | -0.006 | -0.371 | -0.441 | -2.349 | 0.071 | 9.101 | 27.723 | 9.801 | 10.008 |
| Financing Cash Flow
| 43.25 | -1.346 | 40.746 | -0.803 | 49.616 | 109.378 | 0.271 | 78.79 | 27.778 | 9.801 | 10.008 |
| Other Information: | |||||||||||
| Effect Of Forex Changes On Cash
| -1.579 | 0.521 | -0.07 | -0.703 | -0.826 | -1.179 | -4.168 | 3.443 | 1.598 | 0.009 | 0.197 |
| Net Change In Cash
| 46.908 | -50.63 | -78.677 | -32.694 | 37.125 | 32.085 | -27.833 | 75.688 | 73.216 | -7.945 | -9.848 |
| Cash At End Of Period
| 78.494 | 31.586 | 82.216 | 160.893 | 193.587 | 156.462 | 124.377 | 152.21 | 76.522 | 3.306 | 11.251 |